3658 results for «391»
3658 results
A case-based approach: finding balance between bleeding and ischemic risk
19 May 2021 – From EuroPCR 2021
Watch this session presented by David Kandzari, Mirvat Alasnag, Emmanouil Brilakis, Chorcheung Frankie Tam and Beatriz Vaquerizo in order to debate case complexity of patient characteristics and complex lesions in HBR patients, to review patient centered clinical judgment and individualised treatment plans, and to analyse current Onyx ONE...
Left atrial appendage closure (LAAc) for stroke prevention - Session with LIVE demonstration
20 May 2021 – From EuroPCR 2021
Watch this session if you want to understand how to select the most suitable patients for LAA closure, to develop an approach to appropriate device selection and procedural planning, to share step-by-step implementation of procedural plans and to explore optimal post procedure follow-up and care.
This session...
Left Main and bifurcation PCI - Session with LIVE demonstration
19 May 2021 – From EuroPCR 2021
Watch this session if you want to understand how to adapt your treatment strategy to the underlying anatomy, to learn the steps of provisional left main PCI and to discuss the pitfalls of provisional left main PCI.
This session was originally presented during EuroPCR 2021.
How to prevent and manage coronary perforation?
19 May 2021 – From EuroPCR 2021
Watch this session if you want to learn about the different types of coronary perforation, to discuss how to predict which situations and coronary anatomies are particularly at risk of coronary perforation, and to share practical tips for rapid and effective management of coronary perforation.
This session...
EuroPCR 2021 Hotlines / Late-Breaking Trials in renal denervation: EFFECTIVENESS
25 May 2021 – From EuroPCR 2021
Find out more about the EFFECTIVENESS trial regarding renal denervation.
Revisiting DK Crush: key steps and pitfalls
19 May 2021 – From EuroPCR 2021
Watch this session if you want to revisit DK Crush PCI step by step, to review the potential pitfalls of DK Crush, and to visualise the limitations of angiography to accurately assess stent geometry at different steps of the procedure.
This session was originally presented during EuroPCR...
Treatment of uncontrolled hypertension: case-based discussion
19 May 2021 – From EuroPCR 2021
Watch this session if you want to share indications and optimal criteria for patient selection.
This session was originally presented during EuroPCR 2021.
Endovascular aortic repair and case-based discussion of complications during peripheral interventions (Part 2)
20 May 2021 – From EuroPCR 2021
This session, which was originally broadcast during EuroPCR 2021, presents 6 cases of unexpected complications of large vessel access in the context of TAVI procedures and enables our experts to discuss their successful management, using a variety of techniques. It highlights the need for a large...
3-year Efficacy Outcomes From the Spyral Htn-on Med Pilot Study: Long Term Effect of Renal Denervation On Blood Pressure Reduction in Patients on Antihypertension Medications
22 Mar 2022
Ali Nazmi Calik provides his take on the long-term results of the SPYRAL HTN-ON MED trial which demonstrated the durable efficacy and safety of RDN in patients who are already on one to three antihypertensive drugs.
Author
GLORIOUS - Efficacy of restrictive versus liberal oxygenation or Exenatide in patients undergoing coronary artery bypass grafting or aortic valve replacement – a randomised clinical trial
21 Nov 2024
Edoardo Zancanaro provides his take on the GLORIOUS trial presented by Sebastian Wiberg at AHA 2024 in Chicago.
Author
EuroPCR 2025 – The FAITAVI trial: angiography versus physiology-guided PCI in patients undergoing TAVI – 12-month follow-up data
21 May 2025
Paris, France, 20-23 May 2025. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during the 2025 edition of EuroPCR. These trials were selected because of their design, results, and potential to impact practice, among them is the...
EuroPCR 2026 – Coronary revascularisation in patients undergoing TAVI
20 May 2026
Paris, France, 19−22 May 2026. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during EuroPCR 2026 and are set to impact practice worldwide. Among them is an individual participant data meta-analysis of 4 randomised controlled trials...
The 2023 ESH Hypertension Guidelines revisit the role of renal denervation
05 Sep 2023
The 2023 European Society of Hypertension (ESH) guidelines were recently presented at the 32nd annual European Meeting on Hypertension and Cardiovascular Protection and simultaneously published in the Journal of Hypertension.1 While wide parts of the guidelines do not substantially differ from the previous 2018 European Society...
Author
Author
Aortic stenosis and coronary artery disease: which should be treated first?
18 Jun 2026
In this review, Henryk Dreger explores the complex interplay between aortic stenosis and coronary artery disease, highlighting the latest evidence on PCI timing and its implications for clinical decision-making.
Author
Transcatheter aortic valve implantation without routine percutaneous coronary intervention: A randomized controlled trial (PRO-TAVI Trial)
29 Mar 2026
Jonathan Curio provides his take on the PRO-TAVI trial presented by Michiel Voskuil at ACC.26 in New Orleans and simultaneously published in The Lancet.
Author
The AQUATIC trial: Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation
01 Sep 2025
Chiara De Biase provides her take on the results of AQUATIC presented by Martine Gilard at ESC Congress 2025 in Madrid.
Author
![The AQUATIC trial [Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation: Rationale for and design of the AQUATIC double-blind randomized trial]](https://www.pcronline.com/var/pcrov3/storage/images/pcronline/news/congress-coverages/esc/2025/aquatic-trial-quitting-versus-using-aspirin-therapy-patients-stabilized-cad-stenting-long-term-oral-anticoagulation/27448089-9-eng-GB/The-AQUATIC-trial-Assessment-of-quitting-versus-using-aspirin-therapy-in-patients-with-stabilized-coronary-artery-disease-after-stenting-who-requi_image_responsive_6.jpg)
A randomized, placebo-controlled trial of chronic total occlusion PCI in stable angina - ORBITA-CTO trial
03 Apr 2026
Kalaivani Mahadevan provides an in-depth analysis of the ORBITA-CTO trial: a first-ever randomised, double-blind, placebo-controlled trial evaluating CTO PCI in stable angina patients.
She also interviewed principal investigators Sarosh Khan and John Davies following the LBCT Scientific Session at ACC.26 in New Orleans and simultaneous publication in...
Author
Author
Author
NEO-MINDSET: Early withdrawal of aspirin after percutaneous coronary intervention for acute coronary syndrome
02 Sep 2025
Daniele Giacoppo reports and provides his perspective on the main results of the ambitious NEOMINDSET trial, presented by Pedro Lemos from the Hospital Israelita Albert Einstein, São Paulo, Brazil, during a Late Breaking Trials session at the ESC Congress 2025 in Madrid, and simultaneously published in the New...
Author
